These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17618307

  • 1. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
    Fantin M, Fischetti C, Trapella C, Morari M.
    Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo' G, Guerrini R, Barnes TA, Lambert DG, Beani L, Bianchi C, Morari M.
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
    Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M.
    Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
    [Abstract] [Full Text] [Related]

  • 4. Towards a receptor for nocistatin?
    Johnson EE, Connor M.
    Br J Pharmacol; 2007 Oct; 152(4):415-6. PubMed ID: 17618302
    [Abstract] [Full Text] [Related]

  • 5. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 6. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T, Akerman S, Goadsby PJ.
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 8. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 9. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
    Inoue M, Kawashima T, Allen RG, Ueda H.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
    [Abstract] [Full Text] [Related]

  • 10. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
    [Abstract] [Full Text] [Related]

  • 11. Pain regulation by nocistatin-targeting molecules: G protein-coupled-receptor and nocistatin-interacting protein.
    Okuda-Ashitaka E, Ito S.
    Vitam Horm; 2015 Dec; 97():147-65. PubMed ID: 25677771
    [Abstract] [Full Text] [Related]

  • 12. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J, Calo G, Guerrini R, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):183-7. PubMed ID: 12595960
    [Abstract] [Full Text] [Related]

  • 13. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G, Agostini S, Broccardo M, Petrella C, Improta G.
    Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R, Calcagno M, Marti M, Borrelli E, Morari M.
    Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
    [Abstract] [Full Text] [Related]

  • 15. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection.
    Zádori ZS, Shujaa N, Köles L, Király KP, Tekes K, Gyires K.
    Peptides; 2008 Dec; 29(12):2257-65. PubMed ID: 18930088
    [Abstract] [Full Text] [Related]

  • 16. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S, Mizoguchi H, Komatsu T, Sakurada C, Tsuzuki M, Sakurada S, Sakurada T.
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [Abstract] [Full Text] [Related]

  • 17. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [Abstract] [Full Text] [Related]

  • 18. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.
    Peptides; 2009 Feb; 30(2):248-55. PubMed ID: 18992780
    [Abstract] [Full Text] [Related]

  • 19. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC, Fan SH, Guerrini R, Caló G.
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [Abstract] [Full Text] [Related]

  • 20. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M, Linari G, Guerrini R, Agostini S, Petrella C, Improta G.
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.